&nbsp;

ocs-chapters-ch8.jpg

Feb 2020

Regimen

ACAL

Cancer Type:

Hematologic

Intent: Palliative

Drugs Used:

acalabrutinib (Unfunded)

Quick Link(s):

Regimen Monograph

Jul 2024

Regimen

BEND+POLA+RITU

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade

Intent: Palliative

Funding:

New Drug Funding Program

Polatuzumab Vedotin with Bendamustine and Rituximab (Biosimilar) - Relapsed or Refractory Diffuse Large B-cell Lymphoma

New Drug Funding Program

Polatuzumab Vedotin with Bendamustine and Rituximab (Biosimilar) - Relapsed or Refractory Diffuse Large B-cell Lymphoma

New Drug Funding Program

Polatuzumab Vedotin with Bendamustine and Rituximab (Biosimilar) - Relapsed or Refractory Diffuse Large B-cell Lymphoma

Drugs Used:

Quick Link(s):

Regimen Monograph

Nov 2024

Regimen

LIPOCYTADAUN(CONS)

Cancer Type:

Hematologic

Intent: Curative, Palliative

Funding:

New Drug Funding Program

Liposomal Daunorubicin and Liposomal Cytarabine (Outpatient) - Previously Untreated Acute Myeloid Leukemia

liposomal DAUNOrubicin / liposomal cytarabine

Drugs Used:

Quick Link(s):

Regimen Monograph

Dec 2023

Regimen

VENE+OBIN

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - in Combination with Venetoclax for Previously Untreated Chronic Lymphocytic Leukemia

Exceptional Access Program

venetoclax - in Combination with Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia

Drugs Used:

oBINutuzumab,

venetoclax

Quick Link(s):

Regimen Monograph

Jun 2023

Regimen

LENV

Cancer Type:

Gastrointestinal,

Hepatobiliary / Liver / Bile Duct

Intent: Palliative

Funding:

Exceptional Access Program

lenvatinib - For the treatment of unresectable advanced hepatocellular carcinoma according to clinical criteria

Drugs Used:

lenvatinib

Quick Link(s):

Regimen Monograph

Mar 2023

Regimen

IBRU+RITU

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Drugs Used:

iBRUtinib (Unfunded),

riTUXimab (Unfunded)

Quick Link(s):

Regimen Monograph

Aug 2020

Document

H-FIT_PCC_4160_CCAM_Poster_EN_FINAL

Feb 2020

Document

H-FIT_PCC_4160_CCAM_Postcard_EN_V05

Feb 2020

Document

H-FIT_PCC_4160_CCAM_Poster_EN_PRINT

Feb 2020

Document

H-FIT_PCC_4160_CCAM_Postcard_EN_PRINT

Feb 2020

Document